Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Alp, Keziban Merve (1) Birchmeier, Walter Prof. Dr. (7) Blankenstein, Thomas Prof. Dr. (2) Blüthgen, Nils (1) Dahlmann, Mathias Dr. (29) Daniel, Peter Prof. Dr. (3) Fritsche, Raphaela Dr. (2) Haas, Simon Dr. rer. nat. (1) Hartl, Kimberly (1) Herse, Florian PD Dr. (1) Holz, Maximilian (1) Horne, Arik (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janke, Jürgen Dr. (1) Janz, Martin Dr. (1) Keller, Ulrich Dr. med. (2) Kobelt, Dennis Dr. (51) Koch, Gudrun (1) Leutz, Achim Prof. Dr. (2) Malchin, Victoria (1) Mertins, Philipp Dr. (4) Na, Il-Kang Dr. (1) Nazare, Marc (1) Nguyen, Tam Hoai Dr. (1) Nimptsch, Katharina Dr. (1) Özerdem, Ceren (1) Pezzutto, Antonio Prof. Dr. (3) Pischon, Tobias Prof. Dr. (1) Popp, Oliver Dr. (3) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Röefzaad, Claudia (1) Schlag, Peter M. Prof. Dr. (378) Schmitt, Clemens Prof. Dr. (2) Schöpe, Paul Curtis (2) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Solé Boldo, Llorenc Dr. rer. nat. (1) Specker, Edgar Dr. (2) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (187) Torke, Sebastian Dr. (3) Uckert, Wolfgang Prof. Dr. (1) Veltsista, Paraskevi Danai (1) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (145) Wenzel, Katrin Dr. (1) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Zimmermann, Karin Dr. (1) (-) Smith, Janice (16) (-) Sperling, Silke Prof. Dr. (1) Entwicklungsneurobiologie (1) Genetik von Angeborenen Herzerkrankungen (3) Proteomics (1) (-) Translationale Onkologie solider Tumore (17) 2006 (1) 2008 (1) 2009 (2) 2010 (1) 2011 (1) 2012 (1) 2013 (1) 2014 (1) 2016 (1) 2017 (2) 2020 (1) 2021 (1) 2022 (1) 2023 (2) 17 Ergebnisse: Active Filter: Smith, JaniceSperling, Silke Prof. Dr.Translationale Onkologie solider Tumore Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 30. Mai 2014 / Oncotarget RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis M. Dahlmann A. Okhrimenko P. Marcinkowski M. Osterland P. Herrmann J. Smith C.W. Heizmann P.M. Schlag U. Stein 12. November 2022 / Nutrients MACC1-dependent antitumor effect of curcumin in colorectal cancer N. Güllü J. Smith P. Herrmann U. Stein 07. Januar 2023 / Int J Mol Sci Cantharidin and its analogue norcantharidin inhibit metastasis-inducing genes S100A4 and MACC1 P.C. Schöpe V. Zinnow M.A. Ishfaq J. Smith P. Herrmann R.H. Shoemaker W. Walther U. Stein 08. Dezember 2023 / Front Oncol GIPC1 regulates MACC1-driven metastasis F. Siegel H. Schmidt M. Juneja J. Smith P. Herrmann D. Kobelt K. Sharma I. Fichtner W. Walther G. Dittmar R. Volkmer F.G. Rathjen P.M. Schlag U. Stein 03. August 2020 / Cells Saffron crudes and compounds restrict MACC1-dependent cell proliferation and migration of colorectal cancer cells N. Güllü D. Kobelt H. Brim S. Rahman L. Timm J. Smith A. Soleimani S. Di Marco S. Bisti H. Ashktorab U. Stein 26. August 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein 01. August 2012 / Clin Exp Metastasis In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice A. Pichorner U. Sack D. Kobelt I. Kelch F. Arlt J. Smith W. Walther P.M. Schlag U. Stein 01. August 2009 / Cell Cycle MACC1 controls Met: What a difference an Sp1 site makes U. Stein J. Smith W. Walther F. Arlt 01. November 2006 / Gastroenterology The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor (TCF) signaling in colon cancer U. Stein F. Arlt W. Walther J. Smith T. Waldman E.D. Harris S.D. Mertins C.W. Heizmann D. Allard W. Birchmeier P.M. Schlag R.H. Shoemaker 02. Dezember 2010 / PLoS Genet Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells K. Juerchott R.J. Kuban T. Krech N. Blüthgen U. Stein W. Walther C. Friese S.M. Kielbasa U. Ungethuem P. Lund T. Knoesel W. Kemmner M. Morkel J. Fritzmann P.M. Schlag W. Birchmeier T. Krueger S. Sperling C. Sers H.D. Royer H. Herzel R. Schaefer Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
30. Mai 2014 / Oncotarget RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis M. Dahlmann A. Okhrimenko P. Marcinkowski M. Osterland P. Herrmann J. Smith C.W. Heizmann P.M. Schlag U. Stein
12. November 2022 / Nutrients MACC1-dependent antitumor effect of curcumin in colorectal cancer N. Güllü J. Smith P. Herrmann U. Stein
07. Januar 2023 / Int J Mol Sci Cantharidin and its analogue norcantharidin inhibit metastasis-inducing genes S100A4 and MACC1 P.C. Schöpe V. Zinnow M.A. Ishfaq J. Smith P. Herrmann R.H. Shoemaker W. Walther U. Stein
08. Dezember 2023 / Front Oncol GIPC1 regulates MACC1-driven metastasis F. Siegel H. Schmidt M. Juneja J. Smith P. Herrmann D. Kobelt K. Sharma I. Fichtner W. Walther G. Dittmar R. Volkmer F.G. Rathjen P.M. Schlag U. Stein
03. August 2020 / Cells Saffron crudes and compounds restrict MACC1-dependent cell proliferation and migration of colorectal cancer cells N. Güllü D. Kobelt H. Brim S. Rahman L. Timm J. Smith A. Soleimani S. Di Marco S. Bisti H. Ashktorab U. Stein
26. August 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein
01. August 2012 / Clin Exp Metastasis In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice A. Pichorner U. Sack D. Kobelt I. Kelch F. Arlt J. Smith W. Walther P.M. Schlag U. Stein
01. August 2009 / Cell Cycle MACC1 controls Met: What a difference an Sp1 site makes U. Stein J. Smith W. Walther F. Arlt
01. November 2006 / Gastroenterology The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor (TCF) signaling in colon cancer U. Stein F. Arlt W. Walther J. Smith T. Waldman E.D. Harris S.D. Mertins C.W. Heizmann D. Allard W. Birchmeier P.M. Schlag R.H. Shoemaker
02. Dezember 2010 / PLoS Genet Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells K. Juerchott R.J. Kuban T. Krech N. Blüthgen U. Stein W. Walther C. Friese S.M. Kielbasa U. Ungethuem P. Lund T. Knoesel W. Kemmner M. Morkel J. Fritzmann P.M. Schlag W. Birchmeier T. Krueger S. Sperling C. Sers H.D. Royer H. Herzel R. Schaefer